The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Biotech stocks came under pressure this week along with the broader market, which succumbed to the negative sentiment generated by U.S.-China trade tensions. However, they recouped some of these losses, courtesy of ASCO abstracts that were made available online late Wednesday.

Among other notable events, Insys Therapeutics Inc (NASDAQ: INSY) warned of a possible bankruptcy filing, weighed down by legal woes; and the FDA finalized guidelines regarding interchangeable biosimilars.